l carnitina pomada Benavidez Gel Corporal con L-Carnitina –

GHK-CU is not FDA-approved for any medical indication

doi: 10.3390/ANTIOX12091674 272 NanceSADuncanAVGwathmeyTMHairstonKG

If administered to hSOD1 G93A /hCCS mice during the presymptomatic disease phase Cu II (atsm) prevented the development of ALS altogether, [154] whilst administration to hSOD1 G93A and hSOD1 G37R mice after symptom onset markedly improved locomotor function and survival time.[ 228 , 230 ] Importantly, the therapeutic benefit of this compound across numerous mutant SOD1 transgenic mouse strains has been independently verified by multiple research groups.[ 154 , 231 ] Accordingly, phase II/III clinical trials of Cu II (atsm) have recently begun in a small cohort of ALS patients ( n= 80

Cells 12:2190